GGrantIndex
← Leaderboards

Chloe E. Atreya

University Of California, San Francisco

$2,763,065
Attributed
$4,659,429
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $680.6K · FY201325
$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,659,429 · 3

By mechanism

R01$3,414,721 · 1
K08$866,700 · 1
R21$378,008 · 1

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Response

Research focus

ResponsePharmaceutical PreparationsResistanceDrug ResistanceCancer EtiologyCessation Of LifeColorectal CancerMetastatic ColorectalPathway InteractionsGeneticSignal PathwayPhosphotransferasesSamplingMutationSignal TransductionClinical TrialsCell LineResourcesEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEpidermal Growth Factor ReceptorColon Cancer PatientsBraf GeneDrug TestingTumor

Grant awards (14)

Kinome-guided Targeting of Cooperative Dependencies in BRAF Mutated Colorectal Cancer$680,600
R01 · FY2025 · CA
Kinome-guided Targeting of Cooperative Dependencies in BRAF Mutated Colorectal Cancer$679,736
R01 · FY2024 · CA
Kinome-guided Targeting of Cooperative Dependencies in BRAF and KRAS Mutated Colorectal Cancer$397,512
R01 · FY2023 · CA · contact PI
Kinome-guided Targeting of Cooperative Dependencies in BRAF and KRAS Mutated Colorectal Cancer$402,194
R01 · FY2022 · CA · contact PI
Kinome-guided Targeting of Cooperative Dependencies in BRAF and KRAS Mutated Colorectal Cancer$414,144
R01 · FY2021 · CA · contact PI
Kinome-guided Targeting of Cooperative Dependencies in BRAF and KRAS Mutated Colorectal Cancer$418,005
R01 · FY2020 · CA · contact PI
Kinome-guided Targeting of Cooperative Dependencies in BRAF and KRAS Mutated Colorectal Cancer$422,530
R01 · FY2019 · CA · contact PI
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomes$169,262
R21 · FY2019 · CA
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomes$208,746
R21 · FY2018 · CA
Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models$173,340
K08 · FY2017 · CA · contact PI
Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models$173,340
K08 · FY2016 · CA · contact PI
Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models$173,340
K08 · FY2015 · CA · contact PI
Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models$173,340
K08 · FY2014 · CA · contact PI
Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models$173,340
K08 · FY2013 · CA · contact PI